SPOTLIGHT -
Director, Montefiore Multiple Sclerosis Center, Montefiore Health System
Future of Relapsing MS Management
Key opinion leaders in multiple sclerosis (MS) discuss the future of relapsing MS management and unmet needs.
Biomarkers for Monitoring Treatment Response in Relapsing MS
Expert neurologists discuss current and future biomarkers relevant to relapsing multiple sclerosis including cerebrospinal fluid neurofilament.
Shared Decision Making and Lifestyle Issues in Relapsing MS
A panel of experts emphasize the importance of shared decision making in relapsing multiple sclerosis and discuss lifestyle choices that impact the disease.
Sequencing Therapies in Relapsing MS
Experts in multiple sclerosis (MS) discuss key factors involved in the sequencing of therapies for relapsing MS.
Monitoring Outcomes in Relapsing MS
Lauren Gluck, MD discusses considerations for monitoring response to treatment in relapsing multiple sclerosis.
Overview of Teriflunomide for Relapsing MS
Lauren Gluck, MD, and Ravi Dukkipati, MD, provide an overview of teriflunomide for relapsing multiple sclerosis including its safety and tolerability profile.
Considerations for the Use of Fumarates in Relapsing MS
Experts in the field of multiple sclerosis provide insight into the fumarates as a viable oral option for relapsing MS.
Anti-CD20 Agents for Relapsing MS
A panel of experts discuss the use of anti-CD20 monoclonal antibodies in relapsing multiple sclerosis including summaries of the phase III ORATORIO and ASCLEPIOS trials, for ocrelizumab and ofatumumab, respectively.
Role of S1P Receptor Modulators in Relapsing MS
Expert neurologists discuss the role of sphingosine-1-phosphate (S1P) receptor modulators in relapsing multiple sclerosis including vaccine considerations and pediatric use.
Cladribine in Relapsing MS
Key opinion leaders provide insight into the use cladribine for relapsing multiple sclerosis including durability and safety profile.
Cladribine: History and Mechanism of Action in MS
Gavin Giovannoni, MD provides an overview of the development and pharmacodynamics of cladribine in multiple sclerosis.
Platform Agents for MS: Interferons and Glatiramer
Fred D. Lublin, MD, Ravi Dukkipati, MD, and Lauren Gluck, MD, discuss interferons and glatiramer as platform therapies in multiple sclerosis.
Treatment Strategy for Relapsing MS
Experts in multiple sclerosis (MS) provide an overview of treatment strategies and selection in relapsing MS.
The Diagnosis of Multiple Sclerosis
Fred D. Lublin, MD discusses the diagnosis of multiple sclerosis and the 2017 revisions of the McDonald criteria.
Combatting Social Isolation in the COVID Era for Patients With MS
With the COVID era changing social environments and interactions, making sure patients can maintain social connections is as important as ever.
